Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2020-05-01
2022-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of the Intestinal Microbiota During a Real Life Dietary Intervention in Subjects With Overweight or Obesity
NCT04822948
Pediatric Metabolic Syndrome Study
NCT03570840
Clinical and Metabolic, Immunological and Microbiological Characteristics of Obese Patients
NCT05920785
Microbiota in Dietary Approach to Obesity
NCT04453150
Determination of Risk Factors for the Development of Obesity and Hypertension in Children According to Perinatal Programming of Metabolism
NCT04611412
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Obese subjects
Subjects with obesity
Obese with or without metabolic syndromesubjects
Children with obesity and with or without metabolic syndrome
Obese plus metabolic syndrome subjects
Subjects with obesity and metabolic syndrome
Obese with or without metabolic syndromesubjects
Children with obesity and with or without metabolic syndrome
Healthy controls
Otherwise healthy subjects
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Obese with or without metabolic syndromesubjects
Children with obesity and with or without metabolic syndrome
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis of obesity or obesity complicated by metabolic syndrome
* healthy controls
Exclusion Criteria
* concomitant presence of chronic diseases,
* neoplasms,
* immunodeficiencies,
* chronic infections,
* autoimmune diseases,
* chronic inflammatory bowel diseases,
* celiac disease, -genetic-metabolic diseases, -
* cystic fibrosis
* chronic lung diseases,
* malformations of the cardiovascular/respiratory/gastrointestinal system,
* neuropsychiatric disorders
* neurological pathologies,
* assumption of antibiotics and/or pre/pro/synbiotics
* onset of diarrhea or acute gastrointestinal disease during the 12 weeks prior to enrollment.
10 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federico II University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Roberto Berni Canani
MD, Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Naples Federico II
Naples, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
103/20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.